ArticleDiscover oncology2025

Clinical study of aumolertinib versus osimertinib in the treatment of EGFR-mutated advanced non-small cell lung cancer.

Sheng-Xi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.